Cancer specialist Carcinotech lands £4.2m funding deal
Edinburgh-based Carcinotech has raised £4.2m as it prepares to expand into the US with its cancer treatment technology
Stay updated with breaking news from David Milroy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Edinburgh-based Carcinotech has raised £4.2m as it prepares to expand into the US with its cancer treatment technology
Need-to-know Scottish business stories: Carcinotech, Buzzwork Holdings and Holyrood Distillery
Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor Maven Capital Partners (Maven) and £1 million from existing investor, Gresham House Ventures (Gresham House).
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Yirra Yaakin Theatre Company marks three decades of sharing Indigenous stories with the world.